Filter
197
Filtered Results: 197
Text search:
dolutegravir
Featured
Recommendations
22
New Publications
44
Language
Document type
No document type
87
Guidelines
46
Studies & Reports
38
Manuals
9
Strategic & Response Plan
7
Fact sheets
4
Training Material
2
Situation Updates
2
Infographics
2
Countries / Regions
Global
9
South Africa
9
Argentina
7
Malawi
5
Latin America and the Carribbean
5
Namibia
5
Kenya
4
Brazil
4
Colombia
3
Africa
3
Venezuela
2
South–East Asia Region
2
Botswana
2
Myanmar / Burma
2
Nepal
1
Thailand
1
Ukraine
1
Lesotho
1
Rwanda
1
Chile
1
Nigeria
1
Burkina Faso
1
Peru
1
Zimbabwe
1
Philippines
1
Guinea
1
Mozambique
1
Congo, Democratic Republic of
1
Western Pacific Region
1
Western and Central Europe
1
North America
1
Bolivia
1
Uganda
1
Central African Republic
1
Ethiopia
1
Chad
1
Zambia
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
52
Clinical Guidelines
28
Women & Child Health
4
Public Health
2
Pharmacy & Technologies
2
Key Resources
1
Toolboxes
HIV
124
TB
15
Pharmacy
11
COVID-19
4
AMR
4
NTDs
3
Mental Health
2
Refugee
2
Conflict
2
Malaria
1
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
Regional action plan 2019-2023
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
This status report shows how far we have come—and how much further we must go—if we hope to meet the global commitments to end AIDS in children. It offers a snapshot of global progress and permits an early assessment of the impact of the Global Alliance’s work.
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
These guidelines – an update to the World Health Organization’s 2015 publication Consolidated strategic information guidelines – present a set of essential aggregate indicators and guidance on choosing, collecting and systematically analysing strategic information to manage and monitor the nat...
The Guide to operationalize HIV viral load testing HIV presents 60 lessons learnt from the project in a systemic approach including: viral load strategy, laboratories, procurement and supply management, patient care and economy.
An historic opportunity to end AIDS as a public health threat by 2030 and launch a new era of sustainability
A decade of progress has inspired the once unthinkable—that the AIDS epidemic can be ended as a public health threat. The global community has embraced the bold idea to end the AIDS ep...
A decade of progress has inspired the once unthinkable—that the AIDS epidemic can be ended as a public health threat. The global community has embraced the bold idea to end the AIDS ep...
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol...
Evidence-to-Decision and Grade tables
Report
A Project of the Joep Lange Institute July, 2018
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
